stockportfolio.pro
Abrdn Healthcare Investors (HQH)
Financial Services · Asset Management · NYSE
Abrdn Healthcare Investors revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $-192.26M | $58.12M | $186.46M | $99.81M |
| Gross profit | — | — | — | — |
| Net income | $-194.23M | $56.33M | $184.95M | $98.61M |
| Net margin | 101.0% | 96.9% | 99.2% | 98.8% |
Source: Abrdn Healthcare Investors SEC filings (10-K).
Explore 4 years of Abrdn Healthcare Investors financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track HQH in your portfolio →
Abrdn Healthcare Investors financial history by metric
About Abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Abrdn Healthcare Investors — frequently asked questions
What is Abrdn Healthcare Investors's revenue?
Abrdn Healthcare Investors (HQH) reported revenue of $99.81M for fiscal year 2025, down 46.5% from the prior year, according to its SEC filings.
Is Abrdn Healthcare Investors profitable?
Yes. HQH earned net income of $98.61M in fiscal 2025, a net margin of 98.8%.
What is HQH's P/E ratio?
Abrdn Healthcare Investors trades at a price-to-earnings ratio of about 4.3 based on the latest data in our nightly-refreshed cache.
How much debt does Abrdn Healthcare Investors have?
As of fiscal year 2025, HQH carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Abrdn Healthcare Investors's market cap?
Abrdn Healthcare Investors (HQH) has a market capitalization of about $1.09B, based on the latest data in our nightly-refreshed cache.
When does Abrdn Healthcare Investors's fiscal year end?
HQH's fiscal year ends in September. Its most recent annual filing covers the fiscal year ending 2025-09-30.
Where does this data come from?
All figures are computed from Abrdn Healthcare Investors's official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.